T-Cell Tolerant Fraction Can Predict Immunotherapy Toxicity

MONDAY, Aug. 21, 2023 -- The T-cell tolerant fraction predicts clinically significant immune-related adverse events (irAEs) among patients with cancer treated with immune checkpoint inhibitors (ICIs), according to a study published in the August...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news